Results 261 to 270 of about 3,155,563 (287)

Moving towards personalized treatments of immune-related adverse events

Nature Reviews Clinical Oncology, 2020
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese   +2 more
exaly  

Determining the No-Observed-Adverse-Effect Level in Continuous Response

1993
Yasuki Kikuchi, Takashi Yanagawa, Harutoshi Nishiyama   +2 more
openaire   +1 more source

Management of common adverse effects of antipsychotic medications

World Psychiatry, 2018
T Scott Stroup
exaly  

Statistical uncertainty in the no-observed-adverse-effect level*1

Fundamental and Applied Toxicology, 1989
openaire   +1 more source

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature Reviews Clinical Oncology, 2019
Gerasimos P Sykiotis, Faiza Lamine, Camillo Ribi   +2 more
exaly  

No Observable Adverse Effect Level (NoAEL)

2011
openaire   +1 more source

Predicting adverse drug reactions

Nature Reviews Drug Discovery, 2012
Harrison Charlotte
exaly  

No Observable Adverse Effect Level (NoAEL)

2006
openaire   +1 more source

Does adjuvant ipilimumab have little adverse effect on quality of life?

Nature Reviews Clinical Oncology, 2017
Paul Lorigan, Adele C Green, Lorigan Paul   +2 more
exaly  

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C

Nature Reviews Gastroenterology and Hepatology, 2011
Mark S Sulkowski, Curtis Cooper, Bela Hunyady   +2 more
exaly